Alembic Pharmaceuticals Limited — Updates, 18-02-2026: General Updates
18-02-2026 | 10:59 pm
18-02-2026 | 10:59 pm
Alembic Pharma's Karakhadi Injectable Facility (F-3) completed its USFDA inspection with two observations. Crucially, none of these relate to data integrity. The company plans to address the observations as per timelines.
No comments yet. Be the first to comment!
